TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

NCT04323657 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Hodgkin Lymphoma
Acute Lymphoblastic Leukemia
Diffuse Large B Cell Lymphoma
Primary Mediastinal Large B Cell Lymphoma
Mantle Cell Lymphoma
Follicular Lymphoma

Interventions

DRUG: TC-110 T Cells
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

TCR2 Therapeutics